封面
市場調查報告書
商品編碼
1771029

病毒學樣本採集市場-全球產業規模、佔有率、趨勢、機會和預測(按產品類型、樣本、地區和競爭細分,2020-2030 年)

Virology Specimen Collection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Sample, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年,全球病毒學樣本採集市場規模為65億美元,預計2030年將達到84.7億美元,預測期內複合年成長率為4.51%。免疫測定、核酸擴增技術、PCR方法、質譜分析和新一代定序(NGS)等樣本採集技術的進步推動了該市場的發展,這些技術旨在為各種病毒感染提供快速且準確的診斷。此外,製藥和生物製藥產業不斷增加的研發投入也進一步推動了需求。生物製藥領域對大分子藥物開發的日益關注也促進了未來幾年市場的擴張。

市場概覽
預測期 2026-2030
2024年市場規模 65億美元
2030年市場規模 84.7億美元
2025-2030 年複合年成長率 4.51%
成長最快的領域 拭子
最大的市場 北美洲

關鍵市場促進因素

全球病毒感染負擔不斷增加

主要市場挑戰

品質控制和標準化問題

主要市場趨勢

標本處理的自動化和數位化

目錄

第 1 章:產品概述

第2章:研究方法

第3章:執行摘要

第4章:顧客之聲

第5章:全球病毒學樣本採集市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品類型(病毒運送培養基、檢體採集管、拭子、血液採集試劑盒)
    • 依樣本(血液樣本、子宮頸樣本、鼻腔樣本、鼻咽樣本、喉嚨樣本、口腔樣本、其他樣本)
    • 按地區(北美、歐洲、亞太、南美、中東和非洲)
    • 按公司分類(2024)
  • 市場地圖
  • 依產品類型
  • 按樣本
  • 按地區

第6章:北美病毒學樣本採集市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章:歐洲病毒學樣本採集市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章:亞太病毒學樣本採集市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章:南美洲病毒學樣本採集市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章:中東和非洲病毒學樣本採集市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章:市場動態

  • 驅動程式
  • 挑戰

第 12 章:市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章:全球病毒學樣本採集市場:SWOT 分析

第 14 章:波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章:競爭格局

  • Becton, Dickinson and Company
  • Quidel Corporation
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech PLC
  • Titan Biotech Ltd.
  • DiaSorin SpA
  • Vircell SL
  • Copan Italia SPA
  • Puritan Medical Products Co.
  • Hardy Diagnostics

第 16 章:策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 15096

The Global Virology Specimen Collection Market was valued at USD 6.50 billion in 2024 and is projected to reach USD 8.47 billion by 2030, growing at a CAGR of 4.51% during the forecast period. The market is being propelled by advancements in specimen collection technologies such as immunoassays, nucleic acid amplification techniques, PCR methods, mass spectrometry, and next-generation sequencing (NGS), all aimed at delivering fast and accurate diagnostics for various viral infections. In addition, increasing investment in research and development within the pharmaceutical and biopharmaceutical sectors is further driving demand. The growing focus on large molecule drug development in biopharmaceuticals is also contributing to the market's expansion over the coming years.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 6.50 Billion
Market Size 2030USD 8.47 Billion
CAGR 2025-20304.51%
Fastest Growing SegmentSwabs
Largest MarketNorth America

Key Market Drivers

Rising Global Burden of Viral Infections

The growing prevalence and recurrence of viral infections worldwide are key factors accelerating the virology specimen collection market. Conditions such as HIV, hepatitis, influenza, respiratory syncytial virus (RSV), and the recent emergence of COVID-19 necessitate reliable diagnostic practices that begin with high-quality specimen collection. According to the World Health Organization (WHO), seasonal influenza alone causes between 290,000 and 650,000 respiratory deaths annually. Additionally, WHO's 2023 hepatitis report revealed that 254 million people are living with chronic hepatitis B and 50 million with hepatitis C. These figures highlight the critical need for ongoing viral load testing and effective sample collection protocols to support timely diagnosis and treatment.

Key Market Challenges

Quality Control and Standardization Issues

Ensuring consistent quality and standardization in specimen collection across varied environments presents a significant challenge, particularly in low-resource or high-demand outbreak situations. Accurate diagnostic outcomes depend on the integrity of the specimen from collection to analysis, which can be compromised by inconsistent handling procedures, equipment variation, and lack of trained personnel. Although global agencies like WHO and CDC have outlined standard operating procedures, adherence remains uneven-especially in community-level or decentralized settings. For instance, WHO's guidance during the COVID-19 pandemic stressed that improper specimen collection contributed to false-negative results, even in high-income countries. Challenges such as incorrect swab usage or inadequate temperature control during transport can severely impact diagnostic reliability.

Key Market Trends

Automation and Digitalization in Specimen Handling

A key trend reshaping the virology specimen collection market is the adoption of automation and digital tools in specimen management. Automated systems reduce manual errors, maintain sample integrity, and streamline the overall process from collection to analysis. Technologies such as barcoded specimen tubes, automated swab collection, electronic order entry, and laboratory information management systems (LIMS) are enhancing operational efficiency. These innovations ensure chain-of-custody, improve tracking, and minimize contamination risks. During the COVID-19 crisis, digital health platforms enabled home-based sample collection and automatic result reporting to centralized databases, illustrating the scalability and effectiveness of integrated tech-enabled solutions in virology diagnostics.

Key Market Players

  • Becton, Dickinson and Company
  • Quidel Corporation
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech PLC
  • Titan Biotech Ltd.
  • DiaSorin S.p.A.
  • Vircell S.L.
  • Copan Italia S.P.A.
  • Puritan Medical Products Co.
  • Hardy Diagnostics

Report Scope:

In this report, the Global Virology Specimen Collection Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Virology Specimen Collection Market, By Product Type:

  • Viral Transport Media
  • Specimen Collection Tubes
  • Swabs
  • Blood Collection Kits

Virology Specimen Collection Market, By Sample:

  • Blood Samples
  • Cervical Samples
  • Nasal Samples
  • Nasopharyngeal Samples
  • Throat Samples
  • Oral Samples
  • Other Samples

Virology Specimen Collection Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Virology Specimen Collection Market.

Available Customizations:

Global Virology Specimen Collection Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Virology Specimen Collection Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
    • 5.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
    • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.4. By Company (2024)
  • 5.3. Market Map
  • 5.3.1 By Product Type
  • 5.3.2 By Sample
  • 5.3.3 By Region

6. North America Virology Specimen Collection Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
    • 6.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Virology Specimen Collection Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Sample
    • 6.3.2. Canada Virology Specimen Collection Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Sample
    • 6.3.3. Mexico Virology Specimen Collection Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Sample

7. Europe Virology Specimen Collection Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
    • 7.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Virology Specimen Collection Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Sample
    • 7.3.2. Germany Virology Specimen Collection Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Sample
    • 7.3.3. United Kingdom Virology Specimen Collection Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Sample
    • 7.3.4. Italy Virology Specimen Collection Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Sample
    • 7.3.5. Spain Virology Specimen Collection Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Sample

8. Asia-Pacific Virology Specimen Collection Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
    • 8.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Virology Specimen Collection Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Sample
    • 8.3.2. India Virology Specimen Collection Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Sample
    • 8.3.3. Japan Virology Specimen Collection Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Sample
    • 8.3.4. South Korea Virology Specimen Collection Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Sample
    • 8.3.5. Australia Virology Specimen Collection Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Sample

9. South America Virology Specimen Collection Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
    • 9.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Virology Specimen Collection Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Sample
    • 9.3.2. Argentina Virology Specimen Collection Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Sample
    • 9.3.3. Colombia Virology Specimen Collection Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Sample

10. Middle East and Africa Virology Specimen Collection Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
    • 10.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Virology Specimen Collection Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Sample
    • 10.3.2. Saudi Arabia Virology Specimen Collection Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Sample
    • 10.3.3. UAE Virology Specimen Collection Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Sample

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Virology Specimen Collection Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Becton, Dickinson and Company
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Quidel Corporation
  • 15.3. Thermo Fisher Scientific Inc.
  • 15.4. Trinity Biotech PLC
  • 15.5. Titan Biotech Ltd.
  • 15.6. DiaSorin S.p.A.
  • 15.7. Vircell S.L.
  • 15.8. Copan Italia S.P.A.
  • 15.9. Puritan Medical Products Co.
  • 15.10. Hardy Diagnostics

16. Strategic Recommendations

17. About Us & Disclaimer